Tran Kristy, Beutner Gregory L, Schmidt Michael, Janey Jacob, Chen Ke, Rosso Victor, Eastgate Martin D
Chemical Development, Bristol-Myers Squibb, One Squibb Drive, New Brunswick, New Jersey 08903, United States.
J Org Chem. 2015 May 15;80(10):4994-5003. doi: 10.1021/acs.joc.5b00392. Epub 2015 Apr 30.
The development of a diastereoselective nucleoside phosphorylation is described, which produces a single isomer of a complex nucleoside monophosphate pro-drug. A stable phosphoramidic acid derivative is coupled to the nucleoside, in a process mediated by HATU and quinine, to deliver the coupled product in high chemical yield and good diastereoselectivity. This unusual process was shown to proceed through a dynamic kinetic resolution of a 1:1 mixture of activated phosphonate ester diastereoisomers. The optimized conditions afforded the product with a combined [S,S(P)] and [S,R(P)] in-process yield of 89% and a ∼7:1 [S,S(P):S,R(P)] diastereomeric ratio. Isolation of the major isomer was facilitated by single crystallization from anisole, where the product was obtained in 57% isolated yield, excellent purity (>95%), and a high diastereomeric ratio (>50:1).
描述了一种非对映选择性核苷磷酸化反应的进展,该反应生成了一种复杂核苷单磷酸前药的单一异构体。在HATU和奎宁介导的过程中,一种稳定的磷酰胺酸衍生物与核苷偶联,以高化学产率和良好的非对映选择性提供偶联产物。结果表明,这一不同寻常的过程是通过活化膦酸酯非对映异构体1:1混合物的动态动力学拆分进行的。优化后的条件得到了产物,其[S,S(P)]和[S,R(P)]的合并过程中产率为89%,非对映体比例约为7:1 [S,S(P):S,R(P)]。通过从苯甲醚中进行单晶结晶有助于分离主要异构体,产物的分离产率为57%,纯度极高(>95%),非对映体比例也很高(>50:1)。